News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Nunn Jason Raleigh
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 15,000 options to buy
@ $1.36, valued at
$20.4k
|
|
06/13/2022 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC
Txns:
| Granted 100,000 options to buy
@ $0.43, valued at
$43k
|
|
06/10/2022 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 90,000 options to buy
@ $0.27, valued at
$24.3k
|
|
06/15/2021 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 40,000 options to buy
@ $0.9877, valued at
$39.5k
|
|
06/02/2021 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC
Txns:
| Granted 68,577 options to buy
@ $1.74, valued at
$119.3k
|
|
06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/15/2020 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC
Txns:
| Granted 64,103 options to buy
@ $1.05, valued at
$67.3k
|
|
02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/15/2019 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 46,500 options to buy
@ $0.64, valued at
$29.8k
|
|
06/14/2019 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.
Txns:
| Exercised 3,000 options to buy
@ $0 |
|
06/11/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/06/2019 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.
Txns:
| Granted 6,000 options to buy
@ $9.38, valued at
$56.3k
Granted 3,000 restricted stock units
@ $0 |
|
05/16/2019 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC
Txns:
| Granted 30,000 options to buy
@ $1.34, valued at
$40.2k
|
|
06/14/2018 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.
Txns:
| Granted 6,000 options to buy
@ $9.95, valued at
$59.7k
Granted 3,000 restricted stock units
@ $0 Exercised 3,000 restricted stock units
@ $0 |
|
05/17/2018 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on TREVENA INC
Txns:
| Granted 30,000 options to buy
@ $1.84, valued at
$55.2k
|
|
06/15/2017 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.
Txns:
| Granted 6,000 options to buy
@ $28.01, valued at
$168.1k
Granted 3,000 restricted stock units
@ $0 |
|
06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/30/2016 |
4/A
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.
Txns:
| Granted 10,344 options to buy
@ $28.82, valued at
$298.1k
|
|
06/23/2016 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Dermira, Inc.
Txns:
| Granted 10,344 options to buy
@ $28.82, valued at
$298.1k
|
|
05/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/01/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/25/2012 |
3
| Nunn Jason Raleigh (Director) has filed a Form 3 on HYPERION THERAPEUTICS INC |
01/26/2012 |
4
| Nunn Jason Raleigh (Director) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns:
| Granted 7,000 options to buy
@ $8.18, valued at
$57.3k
|
|
01/28/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/04/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/02/2009 |
3
| Nunn Jason Raleigh (Director) has filed a Form 3 on Transcept Pharmaceuticals Inc |
|
|